METOPROLOL TARTRATE

Product NDC: 61919-415
11-digit product format: 619190415
Labeler code: 61919
Product ID: 61919-415_f213e916-36af-4be8-e053-2995a90a21e1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: METOPROLOL TARTRATE
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Direct_Rx
Application: ANDA077739
Marketing category: ANDA
Marketing start: 2019-08-12
Marketing end: 0000-00-00
Substance: METOPROLOL TARTRATE
Active strength: 50 mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2024-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	61919-415		D	Discontinued by firm	2026-10-05
excluded product	product	61919-415		I	Inactivated by FDA	2026-10-05
excluded package	package	61919-415	61919-415-30	D	Discontinued by firm	2026-10-05
excluded package	package	61919-415	61919-415-30	I	Inactivated by FDA	2026-10-05
excluded package	package	61919-415	61919-415-90	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 51 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-415-90	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-415-30	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	61919-415-30	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-415-90	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-415-30	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	61919-415-30	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-415-90	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-415-30	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	61919-415-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-415-90	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-415-30	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	61919-415-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-415-90	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-415-30	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	61919-415-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-415-90	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-415-30	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	61919-415-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-415-30	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-415-90	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	61919-415-30	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-415-30	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-415-90	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	61919-415-30	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-415-30	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-415-90	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	61919-415-30	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	61919-415-30	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	61919-415-30	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	61919-415-30	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A077739-001	METOPROLOL TARTRATE	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11
A077739-002	METOPROLOL TARTRATE	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11
A077739-003	METOPROLOL TARTRATE	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11
A077739-004	METOPROLOL TARTRATE	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07
A077739-005	METOPROLOL TARTRATE	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-product	TE code
A077739-001	AB
A077739-002	AB
A077739-003	AB
A077739-004	AB
A077739-005	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 167 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-001	METOPROLOL TARTRATE	25MG	TABLET / ORAL	AB	2007-09-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-002	METOPROLOL TARTRATE	50MG	TABLET / ORAL	AB	2007-09-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-003	METOPROLOL TARTRATE	100MG	TABLET / ORAL	AB	2007-09-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-004	METOPROLOL TARTRATE	37.5MG	TABLET / ORAL	AB	2023-12-07	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-005	METOPROLOL TARTRATE	75MG	TABLET / ORAL	AB	2023-12-07	`03ed91905a0d…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 167 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A077739-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-004	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A077739-005	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A077739-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-004	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077739-005	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077739-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-004	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077739-005	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-004	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077739-005	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077739-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-004	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077739-005	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077739-005	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077739-005	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-004	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077739-005	AB	1	`03ed91905a0d…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fac0d979-ed64-4395-be9a-fc0b6f8c0a4f	Product name	1	20260122
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
07ea0487-5434-6896-2497-013a7ee4afbd	Product name	9	20250311
95ced987-af5e-4bea-8119-4e7d4558d21b	Product name	2	20200617
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
9ab5a42a-e77d-486b-bb1f-b343fe664ada	Product name	1	20180430
310125de-e7c0-730d-d178-98b990a0334a	Product name	2	20150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-415-30	2025-01-30	C162847	48780-1	2cef2736-5dac-d83d-e063-dadaa90ab31f	METOPROLOL TARTRATE
61919-415-90	2025-01-30	C162847	48780-1	2cef2736-5dac-d83d-e063-dadaa90ab31f	METOPROLOL TARTRATE

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-415-30	METOPROLOL TARTRATE	30 in 1 BOTTLE	TABLET, FILM COATED	30		4
61919-415-90	METOPROLOL TARTRATE	90 in 1 BOTTLE	TABLET, FILM COATED	90		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-415-30	EA - Each	61919-415	1aedea35-e000-4ccd-bc4a-65d9062c7d4c	1	2018-04-19
61919-415-90	EA - Each	61919-415	69638331-efe3-408e-9367-f33adcdc8914	1	2019-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-415	METOPROLOL TARTRATE TABLET, FILM COATED [DIRECT_RX]	4	Legacy NDC, 2 package rows	20230421_8feccadd-b4d6-231f-e053-2995a90a1f40.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 3 · 41 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Metoprolol Tartrate	METOPROLOL TARTRATE	REMEDYREPACK INC.	c9ccdbc0-0e4e-40c4-aacf-de60deda9fd5	2026-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	REMEDYREPACK INC.	3a236293-35c1-4083-9805-ab40df535083	2026-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	REMEDYREPACK INC.	028b6e4a-1597-4d21-89d0-0bbbad21efa8	2026-07-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	American Health Packaging	0a3ccfd4-8b65-4c7e-b0ba-27ff40d5b5e8	2026-07-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	REMEDYREPACK INC.	ad7a07a1-a05f-4eee-ba0a-69675ffbb6e8	2026-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	Legacy Pharmaceutical Packaging, LLC	20cc66c0-a00b-4643-9819-6e0daed51e5f	2026-03-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	A-S Medication Solutions	e1bb16fa-4f72-44bc-bc33-d7653c13f55c	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	A-S Medication Solutions	5b423eba-0a35-41b0-9338-fa4c6f5c6c7f	2026-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	PD-Rx Pharmaceuticals, Inc.	18f44ba2-d431-4a73-ac78-83e734fde694	2026-01-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	PD-Rx Pharmaceuticals, Inc.	d3628f24-8076-4980-a358-8445ef8260f4	2026-01-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	PD-Rx Pharmaceuticals, Inc.	19678edf-934a-45f3-b5da-94d10e9b3248	2026-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	NuCare Pharmaceuticals, Inc.	47d18ba7-558d-1190-e063-6294a90a958f	2026-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	Northwind Health Company, LLC	f318d14a-9f96-4238-e053-2995a90abc15	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	Northwind Health Company, LLC	f319e981-81ff-22da-e053-2a95a90a2738	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	Northwind Health Company, LLC	d9cbda2a-70d9-74d3-e053-2a95a90aacc1	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	QPharma Inc	2ad0606c-7a90-44bd-a75d-d256de30fbcf	2025-12-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	QPharma Inc	85a638c3-d53c-453d-935c-fcfd31372a45	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	QPharma, Inc.	c0e147a8-36a6-1e61-e053-2a95a90afd62	2025-12-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	PD-Rx Pharmaceuticals, Inc.	f4a4da81-c4d0-4a00-9f08-9029b5d9b5ea	2025-10-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739
Metoprolol Tartrate	METOPROLOL TARTRATE	PD-Rx Pharmaceuticals, Inc.	00de1f16-f979-4dbf-aa60-246ffac8d410	2025-06-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077739 application number: ANDA077739

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
W5S57Y3A5L	METOPROLOL TARTRATE	56392-17-7	METOPROLOL TARTRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
866514	metoprolol tartrate 50 MG Oral Tablet	PSN	8feccadd-b4d6-231f-e053-2995a90a1f40	4
866514	metoprolol tartrate 50 MG Oral Tablet	SCD	8feccadd-b4d6-231f-e053-2995a90a1f40	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
61919-415-30	61919041530	30 TABLET, FILM COATED in 1 BOTTLE (61919-415-30)	2019-08-12	0000-00-00	No	No	Current
61919-415-90	61919041590	90 TABLET, FILM COATED in 1 BOTTLE (61919-415-90)	2019-08-12	0000-00-00	No	No	Current